Trial Profile
A single-center, randomized, double-blind crossover study to evaluate the abuse potential, pharmacokinetics, and safety of milled and intranasally administered extended-release hydrocodone (HYD) in recreational opioid users
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 Mar 2017
Price :
$35
*
At a glance
- Drugs Hydrocodone (Primary)
- Indications Pain
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics; Therapeutic Use
- Sponsors Purdue Pharma
- 06 May 2014 New trial record
- 30 Apr 2014 Results presented at the 33rd Annual Scientific Meeting of the American Pain Society.